In addition to certain types of leukaemia (cancer of the white blood cells), including acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia, doxorubicin is also used to treat certain types of bladder, breast, lung, stomach, and ovarian cancer, Hodgkin’s disease, non-lymphoma, Hodgkin’s and Hodgkin’s lymphoma (AML, ANLL). Additionally, doxorubicin is used both alone and in conjunction with other drugs to treat specific types of soft tissue or bone sarcomas as well as specific types of thyroid cancer (cancer that forms in muscles and bones). Additionally, it is used to treat Wilms’ tumour and neuroblastoma, a cancer that starts in nerve cells and primarily affects children (a type of kidney cancer that occurs in children). Doxorubicin belongs to the anthracycline drug class. It functions by reducing or halting the development of cancer cells within your body.
Doxorubicin is available as a liquid solution or as a powder that must be mixed with liquid before being administered intravenously (into a vein) by a physician or nurse in a healthcare setting. Typically, it is administered once every 21 to 28 days. The sort of drugs you are taking, how well your body reacts to them, and the type of cancer you have will all affect how long your treatment will last.
Privacy Overview